These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 32046886)

  • 1. [Management in a dedicated ward of patients colonized with highly resistant bacteria: Is it worth it?].
    Tackin A; Lawrence C; Godin E; Verheye JC; Davido B
    Med Mal Infect; 2020 Aug; 50(5):454-455. PubMed ID: 32046886
    [No Abstract]   [Full Text] [Related]  

  • 2. [The modular hospital of he Aachen University Clinic. From conception to realization--one year later].
    Schumpelick V; Krones CJ
    Chirurg; 2006 Mar; Suppl():65-7. PubMed ID: 16921610
    [No Abstract]   [Full Text] [Related]  

  • 3. Carbapenemase-producing Acinetobacter baumannii: An outbreak report with special highlights on economic burden.
    Gagnaire J; Gagneux-Brunon A; Pouvaret A; Grattard F; Carricajo A; Favier H; Mattei A; Pozzetto B; Nuti C; Lucht F; Berthelot P; Botelho-Nevers E
    Med Mal Infect; 2017 Jun; 47(4):279-285. PubMed ID: 28343727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preferences, barriers and facilitators for establishing comprehensive stroke units: a multidisciplinary survey.
    O'Rourke F; Chan DK; Chan DL; Man Ding X
    Aust Health Rev; 2013 Jun; 37(3):318-23. PubMed ID: 23701844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Difficulties in providing palliative care in identified palliative care beds: An exploratory survey.
    Calvel L; Blondet LV; Chedotal I; Grosshans D; Lefebvre F; Mounier G; Mangin E; Kopferschmitt MC
    Presse Med; 2019; 48(7-8 Pt 1):e209-e215. PubMed ID: 31421945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Who is to blame?
    Cohen HJ
    Hosp Adm Can; 1978 May; 20(5):32, 34, 36. PubMed ID: 10307574
    [No Abstract]   [Full Text] [Related]  

  • 7. Development of acute stroke units--a cost effective reconfiguration which benefits patients.
    Canavan M; Ni Mhaille G; Mulkerrin EC
    QJM; 2012 Jan; 105(1):99-102. PubMed ID: 22006559
    [No Abstract]   [Full Text] [Related]  

  • 8. Infection control procedures for extensively drug-resistant bacteria and related adverse effects: the experience at the Lyon University Hospitals from 2011 to 2017.
    Gerbier-Colomban S; Dananché C; Marion E; Bénet T; Dupieux C; Dauwalder O; Bryant J; Vanhems P
    Clin Microbiol Infect; 2019 Jul; 25(7):919-920. PubMed ID: 30797060
    [No Abstract]   [Full Text] [Related]  

  • 9. The hidden faces of the epidemiology of antibiotic resistance.
    Bonten MJ; Mascini EM
    Intensive Care Med; 2003 Jan; 29(1):1-2. PubMed ID: 12528013
    [No Abstract]   [Full Text] [Related]  

  • 10. Rational use of antibiotics in the intensive care unit: impact on microbial resistance and costs.
    Geissler A; Gerbeaux P; Granier I; Blanc P; Facon K; Durand-Gasselin J
    Intensive Care Med; 2003 Jan; 29(1):49-54. PubMed ID: 12528022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Excess annual economic burdens from nosocomial infections caused by multi-drug resistant bacteria in Thailand.
    Phodha T; Riewpaiboon A; Malathum K; Coyte PC
    Expert Rev Pharmacoecon Outcomes Res; 2019 Jun; 19(3):305-312. PubMed ID: 30321493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of infection wards--are they worthwhile?
    Chattopadhyay B
    J Hosp Infect; 2001 Feb; 47(2):88-90. PubMed ID: 11170770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nosocomial infections in pediatrics. Epidemiologic studies, importance of research networks. Members of REAPED research].
    Sarlangue J; Hubert P; Dageville C; Boithias C; Gottot S
    Arch Pediatr; 1998; 5 Suppl 2():191s-194s. PubMed ID: 9759257
    [No Abstract]   [Full Text] [Related]  

  • 14. An approach to endemic multi-drug-resistant bacteria in nursing homes.
    Drinka PJ; Crnich CJ
    J Am Med Dir Assoc; 2005; 6(2):132-6. PubMed ID: 15871889
    [No Abstract]   [Full Text] [Related]  

  • 15. [Management of multiresistant bacteria].
    Ramé A
    Rev Infirm; 2006 May; (121):32-3. PubMed ID: 16792047
    [No Abstract]   [Full Text] [Related]  

  • 16. Innovation and teamwork: introducing multidisciplinary team ward rounds.
    Moroney N; Knowles C
    Nurs Manag (Harrow); 2006 Apr; 13(1):28-31. PubMed ID: 16602561
    [No Abstract]   [Full Text] [Related]  

  • 17. Impact of a dedicated intravenous therapy team on nosocomial bloodstream infection rates.
    Meier PA; Fredrickson M; Catney M; Nettleman MD
    Am J Infect Control; 1998 Aug; 26(4):388-92. PubMed ID: 9721390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of a single ward for cohorting patients with infection due to multidrug-resistant organisms.
    Stumpfs DJ; de Souza SB; Konkewicz LR; Lovatto CG; da Silva CF; Teixeira Macedo AB; dos Santos RP
    Infect Control Hosp Epidemiol; 2013 Aug; 34(8):864-5. PubMed ID: 23838234
    [No Abstract]   [Full Text] [Related]  

  • 19. Cost-Effectiveness of a Model Infection Control Program for Preventing Multi-Drug-Resistant Organism Infections in Critically Ill Surgical Patients.
    Jayaraman SP; Jiang Y; Resch S; Askari R; Klompas M
    Surg Infect (Larchmt); 2016 Oct; 17(5):589-95. PubMed ID: 27399263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the support worker in the health-care team.
    Robinson J; Stilwell J
    Nurs Times; 1990 Sep 12-18; 86(37):61-3. PubMed ID: 2119034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.